Innate Pharma (IPHA) Cash & Current Investments (2017 - 2026)
Innate Pharma's Cash & Current Investments came in at $12.67 million for the quarter ended Jun 30, 2026, down 84.6% from $82.31 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Cash & Current Investments (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Cash & Current Investments was $38.76 million, down 55.7% from the prior year.
- Cash & Current Investments carries a five-year compound annual growth rate of 14.5% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Current Investments was $87.42 million in the year ended Dec 31, 2024 (+462.2%), $15.55 million in the year ended Dec 31, 2023 (-32.5%), $23.03 million in the year ended Dec 31, 2022 (-7.9%) and $25 million in the year ended Dec 31, 2021 (+26.8%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Cash & Current Investments in data going back to the quarter ended Dec 31, 2017.
- Year-over-year, Cash & Current Investments increased in 1 of the last four quarters, with growth averaging 75.6%.
- The fastest year-over-year change in Cash & Current Investments over five years came in the quarter ended Dec 31, 2024 (growth of 458.1%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 84.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.53 Bn | 1,098.12 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.66 Bn | 555.53 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.81 Bn | 477.92 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.21 Bn | 312.59 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 290.21 Bn | 254.20 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 264.86 Bn | 238.55 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.58 Bn | 192.98 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.88 Bn | 169.08 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.14 Bn | 117.79 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Innate Pharma | 134.39 Mn | -72.81 Mn | - | 12.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.45 Mn |
| Dec 31, 2025 | 40.30 Mn |
| Jun 30, 2025 | 70.40 Mn |
| Dec 31, 2024 | 84.05 Mn |
| Jun 30, 2024 | 98.30 Mn |
| Dec 31, 2023 | 102.33 Mn |
| Jun 30, 2023 | 96.60 Mn |
| Dec 31, 2022 | 108.19 Mn |
| Jun 30, 2022 | 128.86 Mn |
| Dec 31, 2021 | 135.71 Mn |
| Jun 30, 2021 | 142.01 Mn |
| Dec 31, 2020 | 186.51 Mn |
| Jun 30, 2020 | 166.17 Mn |
| Dec 31, 2019 | 245.18 Mn |
| Dec 31, 2018 | 191.65 Mn |
| Dec 31, 2017 | 138.66 Mn |
API Access
Innate Pharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();